Absence of accelerated atherosclerotic disease progression after intracoronary infusion of bone marrow derived mononuclear cells in patients with acute myocardial infarction—Angiographic and intravascular ultrasound—Results from the TErapia Celular Aplicada al Miocardio Pilot study - 05/08/11
, Adolfo Villa, MD b, e, Hipólito Gutiérrez, MD a, Pedro L. Sánchez, MD, PhD b, Federico Gimeno, MD, PhD a, Maria E. Fernández, PhD b, Oliver Gutiérrez, MD c, Pedro Mota, MD a, Ana Sánchez, MD, PhD d, Javier García-Frade, MD, PhD c, Francisco Fernández-Avilés, MD, PhD, FACC b, Jose A. San Román, MD, PhD, FESC afor the TECAM (TErapia Celular Aplicada al Miocardio) research group
Résumé |
Background |
We tried to evaluate a putative negative effect on coronary atherosclerosis in patients receiving intracoronary infusion of unfractionated bone marrow mononuclear cells (BMMC) following an acute ST-elevation myocardial infarction. Peripheral blood mononuclear cells or enriched CD133+ BMMC have been associated with accelerated atherosclerosis of the distal segment of the infarct related artery (IRA).
Methods |
Thirty-seven patients with ST-elevation myocardial infarction from the TECAM pilot study underwent intracoronary infusion of autologous BMMC 9 ± 3.1 days after onset of symptoms. We compared angiographic changes from baseline to 9 months of follow-up in the distal non-stented segment of the IRA, as well as in the contralateral coronary artery, with a matched control group. A subgroup of 15 treated patients underwent additional IVUS within the distal segment of the IRA.
Results |
No difference between stem cell and control group were found regarding changes in minimum lumen diameter (0.006 ± 0.42 vs 0.06 ± 0.41 mm, P = ns) and the percentage of stenosis (−2.68 ± 12.33% vs −1.78 ± 8.75%, P = ns) at follow-up. Likewise, no differences were seen regarding changes in the contralateral artery (minimum lumen diameter −0.004 ± 0.54 mm vs −0.06 ± 0.35 mm, P = ns). In the intravascular ultrasound substudy, no changes were demonstrated comparing baseline versus follow-up in maximum area stenosis and plaque volume.
Conclusions |
In this pilot study, analysis of a subgroup of patients found that intracoronary injection of unfractionated BMMC in patients with acute ST-elevation myocardial infarction was not associated with accelerated atherosclerosis progression at mid term. Prospective, randomised studies in large cohorts with long-term angiographic and intravascular ultrasound follow-up are necessary to determine the safety of this therapy.
Le texte complet de cet article est disponible en PDF.Plan
Vol 159 - N° 6
P. 1154.e1-1154.e8 - juin 2010 Retour au numéro
Article précédent
- Iatrogenic left main coronary artery dissection: Incidence, classification, management, and long-term follow-up
- Parham Eshtehardi, Patrick Adorjan, Mario Togni, Hendrick Tevaearai, Rolf Vogel, Christian Seiler, Bernhard Meier, Stephan Windecker, Thierry Carrel, Peter Wenaweser, Stéphane Cook
- Left atrial volume index in highly trained athletes
- Antonello D'Andrea, Lucia Riegler, Rosangela Cocchia, Raffaella Scarafile, Gemma Salerno, Rita Gravino, Enrica Golia, Olga Vriz, Rodolfo Citro, Giuseppe Limongelli, Paolo Calabrò, Giovanni Di Salvo, Pio Caso, Maria Giovanna Russo, Eduardo Bossone, Raffaele Calabrò
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?